Consumers are concerned about the quality of commercially available eggs. Eggs used in this study were marketed in Portugal and originated from laying hens raised in cages, barns, free-range, organic eggs, and eggs enriched with n-3 polyunsaturated fatty acids (PUFA), and from native Portuguese breeds. The eggs were analyzed for chemical and physical properties. Results indicated that yolk color was lighter in organic eggs and darker in n-3 PUFA enriched eggs. Eggs from caged hens had lower Haugh units in contrast with organic eggs. Caged hens produced eggs with a higher protein content while organic eggs had the lowest level of protein in the albumen. As might be expected, eggs enriched in n-3 PUFA had the highest n-3 PUFA content. Choosing an egg by its production system or labeling specificities may not be a guarantee of superior product quality. The layer genotype, age, diet, and the quality of the range also may affect egg properties. Due to a different layer diet, enriched eggs seem to be of superior quality.

Objectives To compare the ultrasound characteristics with clinical features, final diagnosis and outcome; and to evaluate the halo size following glucocorticoid treatment in patients with newly diagnosed GCA. Methods Patients with suspected GCA, recruited from an international cohort, had an ultrasound of temporal (TA) and axillary (AX) arteries performed within 7 days of commencing glucocorticoids. We compared differences in clinical features at disease presentation, after 2 weeks and after 6 months, according to the presence or absence of halo sign. We undertook a cross-sectional analysis of the differences in halo thickness using Pearson’s correlation coefficient (r) and Analysis of Variance (ANOVA). Results A total of 345 patients with 6 months follow-up data were included; 226 (65.5%) had a diagnosis of GCA. Jaw claudication and visual symptoms were more frequent in patients with halo sign (P�=0.018 and P�=0.003, respectively). Physical examination abnormalities were significantly associated with the presence of ipsilateral halo (P�<0.05). Stenosis or occlusion on ultrasound failed to contribute to the diagnosis of GCA. During 7 days of glucocorticoid treatment, there was a consistent reduction in halo size in the TA (maximum halo size per patient: r=−0.30, P�=0.001; and all halos r=−0.23, P�<0.001), but not in the AX (P�>0.05). However, the presence of halo at baseline failed to predict future ischaemic events occurring during follow-up. Conclusion In newly diagnosed GCA, TA halo is associated with the presence of ischaemic features and its size decreases following glucocorticoid treatment, supporting its early use as a marker of disease activity, in addition to its diagnostic role.

No abstract

No abstract

No abstract